Irritable Bowel Syndrome

doi:10.1017/9781108877084.012

Chapter 11 - Irritable Bowel Syndrome

Published online by Cambridge University Press: 08 March 2021

Maryam R. Kashi and

Seetha Lakshmanan

Edited by

Michael Hibner

Show author details

Michael Hibner: Affiliation:
St Joseph’s Hospital & Medical Center, Phoenix, AZ

Book contents

Get access

Summary

Irritable bowel syndrome (IBS) is another condition of the “evil quadruplets.” It often coexists with endometriosis and adds to the pain of this condition. The mainstay is pain that is worsened by food and improved by defecation. It is also important to remember that IBS is diagnosed based on symptoms, and endoscopy is often performed in those patients is done to rule out any other bowel disease. This condition is best managed by a gastroenterologist but it is important to note that quite a large number of patients with this condition have spasm of pelvic floor muscles and treatment of that spasm may improve some of the IBS symptoms.

Information

Type: Chapter
Information: Management of Chronic Pelvic Pain
A Practical Manual
, pp. 120 - 128

DOI: https://doi.org/10.1017/9781108877084.012 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Chey, WD, Kurlander, J, Eswaran, S. Irritable bowel syndrome: a clinical review. JAMA. 2015;313(9):949–58.Google Scholar PubMed

Lovell, RM, Ford, AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10:712.CrossRef Google Scholar PubMed

Sayuk, GS, Wolf, R, Chang, L. Comparison of symptoms, healthcare utilization, and treatment in diagnosed and undiagnosed individuals with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol. 2017;112:892–9.CrossRef Google Scholar PubMed

Olafsdottir, LB, Gudjonsson, H, Jonsdottir, HH, Jonsson, JS, et al. Irritable bowel syndrome: physicians’ awareness and patients’ experience. World J Gastroenterol. 2012;18(28):3715–20.CrossRef Google Scholar PubMed

Suttor, VP, Prott, GM, Hansen, RD, Kellow, JE, Malcolm, A. Evidence for pelvic floor dyssynergia in patients with irritable bowel syndrome. Dis Colon Rectum. 2010;53(2):156–60.Google Scholar

Saha, L. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol. 2014;20(22):6759–73.CrossRef Google Scholar PubMed

Alaradi, O, Barkin, J. Irritable bowel syndrome: update on pathogenesis and management. Med Princ Pract. 2002;11(1):2–17.Google Scholar

Camilleri, M. Peripheral mechanisms in irritable bowel syndrome. N Engl J Med. 2012;367(17):1626–35. DOI: 10.1056/NEJMra1207068.Google Scholar

Lee, YJ, Park, KS. Irritable bowel syndrome: emerging paradigm in pathophysiology. World J Gastroenterol. 2014;10(20):2456–69. DOI: 10.3748/wjg.v20.i10.2456.Google Scholar

Altobelli, E, Del Negro, V, Angeletti, PM, et al. Low-FODMAP diet improves irritable bowel syndrome symptoms: a meta-analysis. Nutrients. 2017;9:940; DOI: 10.3390/nu9090940.CrossRef Google Scholar PubMed

Lacy, BE. Rome criteria and a diagnostic approach to irritable bowel syndrome. J Clin Med. 2017;6(11):99.CrossRef Google Scholar

Yang, J, Deng, Y, Chu, H, et al. Prevalence and presentation of lactose intolerance and effects on dairy product intake in healthy subjects and patients with irritable bowel syndrome. Clin Gastroenterol and Hepatol. 2013;11:262–8.Google Scholar

Zhang, Y, Li, L, Guo, C, et al. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis. BMC Gastroenterol. 2016;16(1):62.CrossRef Google Scholar PubMed

Vazquez-Roque, MI, Camelleri, M, Smyrk, T, et al. A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology. 2013;144(5):903–11. e.3.Google Scholar

Camilleri, M, Ford, AC. Pharmacotherapy for irritable bowel syndrome. J Clin Med. 2017;6:101. DOI: 10.3390/jcm6110101.Google Scholar

Rao, S, Lembo, AJ, Shiff, SJ, et al. A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipation. Am J Gastroenterol. 2012;107:1714–24. DOI: 10.1038/ajg.2012.255.CrossRef Google Scholar PubMed

Chey, WD, Lembo, AJ, Lavins, BJ, et al. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety. Am J Gastroenterol. 2012; 107:1702–12; DOI: 10.1038/ajg.2012.254.Google Scholar

Weinberg, DS, Smalley, W, Heidelbaugh, JJ, et al. American Gastroenterological Association Institute guideline on the pharmacological management of irritable bowel syndrome. Gastroenterology. 2014;147:1146–8.Google Scholar

Lembo, AJ, Lacy, BE, Zuckerman, M, et al. Eluxadoline for irritable bowel syndrome with diarrhea. N Engl J Med. 2016;374:242–53. DOI: 10.1056/NEJMoa1505180.CrossRef Google Scholar PubMed

Soares, RL. Irritable bowel syndrome: a clinical review. World J Gastroenterol.Google Scholar

Accessibility standard: Unknown

Accessibility compliance for the PDF of this book is currently unknown and may be updated in the future.